Another vaccine fails to prevent staph infections
Staph infections remain a significant problem for hospital patients, and scientists are trying to develop vaccines to prevent Staphylococcus aureus bacteria from establishing itself in vital areas like the heart, lungs or blood. But it's turning out to be a difficult task: A promising vaccine intended to protect heart-surgery patients from staph infections worked no better than a placebo, a new study reported. Making matters worse, patients who developed staph infections despite getting the vaccine were more likely to die than infected patients who got the placebo, the study found.
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Top-Ranked MA Plans Earn Their Stars
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- How Hospitals Can Become 'Upstreamists'
- 4 Tips for Managing Employed Physicians
- Defensive Medicine Still Prevalent Despite Tort Reform
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening
- Ebola: Health Officials Try to Quell Front Line Fears